Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib

BACKGROUND AND AIMS: Sorafenib is the standard of care for patients with advanced hepatocellular carcinoma (HCC), yet treatment safety may be challenged by portal hypertension. We therefore assessed the prevalence, risk factors and clinical consequences of esophageal varices (EVs) in sorafenib-treat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:United European Gastroenterol J
Autores principales: Iavarone, Massimo, Primignani, Massimo, Vavassori, Sara, Sangiovanni, Angelo, La Mura, Vincenzo, Romeo, Raffaella, Colombo, Massimo
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2015
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924436/
https://ncbi.nlm.nih.gov/pubmed/27403302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615615041
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares